Cigna Group’s Express Scripts reached a settlement with federal antitrust enforcers to resolve allegations that the company artificially inflated the price of insulin for patients through illegal rebate tactics.
The Federal Trade Commission — which filed suit in 2024 — said in a statement Wednesday that Express Scripts would change how it calculates prices for its list of approved drugs. Cigna is one of three pharmacy benefit managers that together control about 80% of prescriptions filled in the US.
The lawsuit against the other two companies, units of CVS Health Corp. and UnitedHealth Group Inc., remains ongoing. Last month, ...
